Literature DB >> 18820583

Mumps epidemiology and immunity: the anatomy of a modern epidemic.

Larry J Anderson1, Jane F Seward.   

Abstract

The success of the measles, mumps, and rubella 2-dose vaccination program led public health officials in 1998 to set a goal to eliminate endemic transmission of mumps virus by 2010 in the United States. The large outbreak of mumps in the spring of 2006 has led public health officials to re-evaluate this goal and to recognize that the transmission and epidemiology of mumps in highly vaccinated populations may be different than anticipated. During 2006, a total of 6584 confirmed and probable cases of mumps were reported to the Centers for Disease Control and Prevention and most of these, 5865, occurred between January 1 and July 31. The peak of the outbreak was in April and seemed to be focused on college campuses in 9 midwestern states with Iowa having the highest attack rate. College campuses with mumps outbreaks included ones with 77% to 97% of students having had 2 doses of a mumps vaccine. Diagnosing mumps proved to be problematic in vaccinated persons (ie, laboratory tests seemed to be insensitive and some apparent mumps cases had mild nonclassic illness). The outbreak demonstrated that mumps can sometimes transmit efficiently in highly vaccinated populations and the clinical and laboratory diagnosis of mumps in vaccinated persons is more difficult than in naive persons. The reason for this mumps outbreak is not clear but probably results from multiple factors contributing to an overall increase in susceptibility and/or transmission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820583     DOI: 10.1097/INF.0b013e3181684d8d

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis.

Authors:  Donald R Latner; Marcia McGrew; Nobia Williams; Luis Lowe; Roniel Werman; Eli Warnock; Kathleen Gallagher; Peter Doyle; Sandra Smole; Susan Lett; Noelle Cocoros; Alfred DeMaria; Raimond Konomi; Cedric J Brown; Paul A Rota; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

2.  The relationship between meteorological factors and mumps incidence in Guangzhou, China, 2005-2012:.

Authors:  Qiongying Yang; Zhicong Yang; Haiyuan Ding; Xiao Zhang; Zhiqiang Dong; Wensui Hu; Xiangyi Liu; Ming Wang; Guifang Hu; Chuanxi Fu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  The Human CD4+ T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope.

Authors:  Jelle de Wit; Maarten E Emmelot; Martien C M Poelen; Josien Lanfermeijer; Wanda G H Han; Cécile A C M van Els; Patricia Kaaijk
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Clinical features of mumps orchitis in vaccinated postpubertal males: a single-center series of 62 patients.

Authors:  Bum Sik Tae; Byeong Kuk Ham; Jae Heon Kim; Jae Young Park; Jae Hyun Bae
Journal:  Korean J Urol       Date:  2012-12-20

Review 5.  Remembering mumps.

Authors:  Donald R Latner; Carole J Hickman
Journal:  PLoS Pathog       Date:  2015-05-07       Impact factor: 6.823

6.  Infectious diseases and vaccination strategies: how to protect the "unprotectable"?

Authors:  Elena Bozzola; Mauro Bozzola; Valeria Calcaterra; Salvatore Barberi; Alberto Villani
Journal:  ISRN Prev Med       Date:  2013-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.